E. Ruttmann, L. J. Brant, H. Concin, G. Diem, K. Rapp and H. Ulmer, Vorarlberg Health Monitoring and Promotion Program Study Group, “Gamma-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality: An Epidemiological Investigation in a Cohort of 163,944 Austrian Adults,” Circulation, Vol. 112, No. 14, 2005, pp. 2130-2137. doi:10.1161/CIRCULATIONAHA.105.552547

has been cited by the following article:

• TITLE: Effect of Lactobacillus brevis SBC8803 on Gamma-Glutamyl Transferase in Japanese Habitual Drinkers: A Double-Blind, Placebo-Controlled Study

  AUTHORS: Yoshihisa Wakita, Hajime Kanda, Chikako Shimizu, Yasukazu Nakakita, Hirotaka Kaneda, Shuichi Segawa, Moeko Ozaki, Tatsuro Shigyo, Takaaki Ohtake, Mikihiro Fujiya, Yutaka Kohgo

  KEYWORDS: Lactobacillus brevis; Gamma-Glutamyl Transferase; Alcoholic Related Disorder; Double-Blind Placebo-Controlled Study

  JOURNAL NAME: Food and Nutrition Sciences, Vol.3 No.5, May 17, 2012

  ABSTRACT: A randomized, double-blind, placebo-controlled clinical trial in Japanese habitual drinkers was conducted to evaluate the efficacy of Lactobacillus brevis SBC8803 to alleviate adverse effect of alcohol. Subjects who drank habitually and had moderately higher levels of gamma-glutamyl transferase (GGT) (50 - 100 IU/L) were enrolled. The levels of transaminases in these subjects were almost within normal levels (aspartate transaminase (AST)